| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 06/11/2002 | US6403381 Using chelate compound |
| 06/11/2002 | US6403349 Elongation of polyunsaturated fatty acid such as linolenic acid to dihomogamma linolenic acid; nucleotide sequence encodes polypeptide; genetic engineering; animal feeds, nutrients, cosmetics |
| 06/11/2002 | US6403336 Dna segment encodes protective peptide-fused atriopeptin; microorganisms transformed with vectors; genetic engineering |
| 06/11/2002 | US6403335 Amino acid sequence; promotes survival of mesencephalic cells; nervous system and degenerative disorders; parkinson*s disease; genetic engineering |
| 06/11/2002 | US6403091 Produced by the hybridoma having atcc accession no. hb 10916. |
| 06/11/2002 | US6403089 Inhibitors of fgl2; bacterial and viral infections, allograft and xenograft rejection, glomerulonephritis, cancer, gastrointestinal diseases and fetal loss; monoclonal and polyclonal antibodies which bind to fgl2 and prevent fibrin |
| 06/06/2002 | WO2002045431A2 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | WO2002044214A1 Methods for the synthesis of a modified hemoglobin solution |
| 06/06/2002 | WO2002044183A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
| 06/06/2002 | WO2002044182A1 Condensed purine derivatives as a1 adenosine receptor antagonists |
| 06/06/2002 | WO2002044179A1 1,4,5,6-tetrahydroimidazo[4,5-d]diazepine derivatives or salts thereof |
| 06/06/2002 | WO2002044167A1 Process for the crystallization of (r)- or (s)-lansoprazole |
| 06/06/2002 | WO2002044165A1 Quinoline derivatives as nk-3 antagonists |
| 06/06/2002 | WO2002044154A1 Novel compounds |
| 06/06/2002 | WO2002044152A1 Indoline derivatives and their use as 5-ht2 receptor ligands |
| 06/06/2002 | WO2002044145A1 New mandelic acid derivatives and their use as throbin inhibitors |
| 06/06/2002 | WO2002044086A2 Sodium zirconium carbonate and zirconium basic carbonate and methods of making the same |
| 06/06/2002 | WO2002043859A2 Cartridges useful in cleaning dialysis solutions |
| 06/06/2002 | WO2002043806A2 In vivo delivery methods and compositions |
| 06/06/2002 | WO2002043735A1 Inhibitors of thrombin induced platelet aggregation |
| 06/06/2002 | WO2002043734A1 Novel compounds |
| 06/06/2002 | WO2002043728A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/06/2002 | WO2002043691A1 Skin cream stimulating the surface bloodstream |
| 06/06/2002 | WO2002043648A2 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | WO2002020489A3 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 06/06/2002 | WO2002011676A3 Method of using diketopiperazines and composition containing them |
| 06/06/2002 | WO2001094333A3 Process for the preparation of benzoyl substituted bicyclic compounds and chiral benzopyran derivatives |
| 06/06/2002 | WO2001090334A3 Drug metabolizing enzymes |
| 06/06/2002 | WO2001090068A3 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases |
| 06/06/2002 | WO2001087849A3 Modulators of tnf- alpha signaling |
| 06/06/2002 | WO2001079442A3 Albumin fusion proteins |
| 06/06/2002 | WO2001068643A3 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines |
| 06/06/2002 | WO2001064907A3 Lipid metabolism enzymes |
| 06/06/2002 | WO2001064884A3 G12l, a gene associated with the thermal response |
| 06/06/2002 | WO2001036645A3 Serine/threonine kinase and serine protease polypeptides and nucleic acids encoding same |
| 06/06/2002 | US20020069422 Proteins for use in the treatment of trypanosome infection, cancer, inflammation and immunological defects |
| 06/06/2002 | US20020068758 Novel orally active iron (III) chelators |
| 06/06/2002 | US20020068748 Diazabicyclooctane derivatives and therapeutic uses thereof |
| 06/06/2002 | US20020068746 Pyrrolo[2,3-d]pyrimidine compounds |
| 06/06/2002 | US20020068731 Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| 06/06/2002 | US20020068723 Altering the conformational equilibrium of the A- ring to favor a chair conformation that presents the 1 alpha-hydroxyl in the axial orientation. |
| 06/06/2002 | US20020068719 Synergy between low molecular weight heparin and platelet aggregation inhibitors, providing a combination therapy for the prevention and treatment of various thromboembolic disorders |
| 06/06/2002 | US20020068319 32 human secreted proteins |
| 06/06/2002 | US20020068303 Protein for us ein the treatment of immunological defects |
| 06/06/2002 | CA2457925A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/06/2002 | CA2430341A1 Genetically engineered herpes virus for the treatment of cardiovascular disease |
| 06/06/2002 | CA2430311A1 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | CA2425892A1 1,4,5,6-tetrahydroimidazo[4,5-d]diazepine derivative or salt thereof |
| 06/05/2002 | EP1211313A2 Modulation of PDE11A activity |
| 06/05/2002 | EP1211305A1 Fat compositions |
| 06/05/2002 | EP1211261A2 Stable polymerized hemoglobin blood-substitute |
| 06/05/2002 | EP1210944A1 Blood plasma replacement solution |
| 06/05/2002 | EP1210605A2 Analysis and treatment of body weight and eating disorders |
| 06/05/2002 | EP1210465A2 A method for producing quality assured biological sample and composition containing the same |
| 06/05/2002 | EP1210455A1 Novel glycosyl sulfotransferases gst-4 alpha, gst-4 beta, and gst-6 |
| 06/05/2002 | EP1210435A1 Fhm, A NOVEL MEMBER OF THE TNF LIGAND SUPERGENE FAMILY |
| 06/05/2002 | EP1210419A2 Human transmembrane proteins |
| 06/05/2002 | EP1210341A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 06/05/2002 | EP1210340A1 Substituted piperazine derivatives, the production thereof and their utilization as medicaments |
| 06/05/2002 | EP1210325A1 Aminobenzophenones as inhibitors of il-1beta and tnf-alpha |
| 06/05/2002 | EP1210130A1 Solid wound healing formulations containing fibronectin |
| 06/05/2002 | EP1210117A2 Compositons for the treatment of cardiovascular diseases containing pyridoxal compounds and cardiovascular compounds |
| 06/05/2002 | EP1210108A2 Use of leptin in inhibition of endothelial cell proliferation |
| 06/05/2002 | EP1210065A1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 06/05/2002 | EP1210063A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 06/05/2002 | EP0711282B1 Compounds as pde iv and tnf inhibitors |
| 06/05/2002 | EP0700299B1 Oxygen-reduced aqueous solution of factor viii |
| 06/05/2002 | CN1352687A A variant of c6 beta-chemokine leukotactin-1 (shLKn-1) with enhanced biological activity |
| 06/05/2002 | CN1352641A Isonipecotamides for the treatment of integrin mediated disorders |
| 06/05/2002 | CN1352554A IL-8 receptor antagaonists |
| 06/05/2002 | CN1352545A 吲哚衍生物 Indole derivatives |
| 06/05/2002 | CN1351867A Levo-potasisum magnesium asparate infusion injection and preparing method |
| 06/04/2002 | US6399784 Efficient method for the conversion of nitriles to amidines |
| 06/04/2002 | US6399648 N-oxides of heterocyclic ester, amide, thioester, or ketone for vision and memory disorders |
| 06/04/2002 | US6399641 For therapy and prophylaxis of psychosis, schizophrenia, alzheimer's disease, cognitive disorders and restricted brain function caused by bypass operations or transplants, poor blood supply to the brain, spinal cord injuries etc. |
| 06/04/2002 | US6399637 Crystal modification of torasemide |
| 06/04/2002 | US6399636 For therapy of asthma, chronic bronchitis, chronic obstructive pulmonary disease (copd), eosinophilic granuloma, psoriasis and septic shock, ulcerative colitis, crohn's disease, reperfusion injury of the myocardium and brain |
| 06/04/2002 | US6399627 Anticoagulants; prothrominase, serine protease inhibitor; acrylamide derivatives |
| 06/04/2002 | US6399376 Modulation of vascular cell adhesive molecule expression through oligonucleotide interactions |
| 06/04/2002 | US6399139 Controlling material handling |
| 06/04/2002 | US6399053 Methods of enhancing bioactivity of chemokines |
| 06/04/2002 | CA2174097C Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides |
| 05/30/2002 | WO2002042336A2 Fgf-affinity chromatography |
| 05/30/2002 | WO2002042333A1 Anti-cd14 monoclonal antibody having effect of inhibiting cd14/tlr binding |
| 05/30/2002 | WO2002042332A2 Truncated cd200 |
| 05/30/2002 | WO2002042306A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 05/30/2002 | WO2002042301A1 Novel pyridine-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042300A1 Novel carbamate-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042299A1 Novel lactame-substituted pyrazolopyridine derivatives |
| 05/30/2002 | WO2002042298A1 Aminothiazoles and their use as adenosine receptor antagonists |
| 05/30/2002 | WO2002042278A2 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 05/30/2002 | WO2002042273A2 Acid derivatives useful as serine protease inhibitors |
| 05/30/2002 | WO2002042272A2 Substituted polycyclic aryl and heteroaryl pyridines useful for selective inhibition of the coagulation cascade |
| 05/30/2002 | WO2002042269A1 3-arylindole derivatives and their use as cb2 receptor agonists |
| 05/30/2002 | WO2002042257A1 Substituted cyclohexane derivates and the use thereof in medicaments for treating cardiovascular diseases |
| 05/30/2002 | WO2002042248A2 Naphthalene derivatives |
| 05/30/2002 | WO2002020736A9 Proteases |
| 05/30/2002 | WO2002018441A3 Electroprocessed fibrin-based matrices and tissues |
| 05/30/2002 | WO2002015919A3 Saratin for inhibiting platelet adhesion to collagen |
| 05/30/2002 | WO2002000611A3 Fmoc-l-leucine and derivatives thereof as ppar-gamma agonists |